tpoxx
(tecovirimat monohydrate)SIGA Technologies, Inc.
Usage: TPOXX® is indicated for treating human smallpox disease caused by the variola virus in adults and pediatric patients weighing at least 3 kg. However, its effectiveness in humans has not been established due to ethical concerns regarding clinical trials, and efficacy may be reduced in immunocompromised patients.